Company’s goal

Biocrine’s goal is to commercialize new concepts of treatment and enable continuous delivery of novel drugs both  for diabetes itself and for the complications that this disease induces.

Focus of research

Diabetes is a complex syndrome of disordered metabolism. At Biocrine, the research goal is to understand what happens in the pancreatic gland; the role and interplay of hormones, receptors, and other molecules. We believe that every molecular event is of importance in the development of this complex disease. It is only by looking at all phenomena in relation to each other, that a clear picture of what leads to diabetes and how to fight it will emerge.

Research team

The flow of innovations stems from the extensive research at the Rolf Luft Research Center for Diabetes and Endocrinology at Karolinska Institutet. The center is one of the leading research institutes in the world focusing on the endocrine part of the pancreas – the islets of Langerhans.

Professor Per-Olof Berggren at the Rolf Luft Research Center is a world-leading scientist in the interpretation of the mechanisms controlling hormone release in the endocrine pancreas. Professor Berggren has worked in this field for over three decades. With new advanced technologies in biochemistry, cellular biology, electrophysiology and molecular biology, his research team has made a number of pioneering discoveries in the field of diabetes.